1 / 1

IMAGINE

IMAGINE. Incidence of CV death, resuscitated cardiac arrest, nonfatal MI, coronary revascularization, unstable angina or heart failure, angina, and stroke 13.7% in quinapril group and 12.2% in placebo group (HR 1.15, 95% CI 0.92-1.42; p = 0.212) over a median duration of 2.95 years

bayle
Download Presentation

IMAGINE

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. IMAGINE Incidence of CV death, resuscitated cardiac arrest, nonfatal MI, coronary revascularization, unstable angina or heart failure, angina, and stroke 13.7% in quinapril group and 12.2% in placebo group (HR 1.15, 95% CI 0.92-1.42; p = 0.212) over a median duration of 2.95 years Primary composite endpoint significantly increased in the first 3 months after CABG in quinapril group (p = 0.04) Trial design: IMAGINE was a double-blinded, randomized, placebo-controlled trial designedto test the effects of early ACE inhibitor initiation (quinapril 10 or 20 mg/day within 7 to 10 days) after CABG in patients with preserved LV function, and no clear indication for ACE inhibitor therapy. Results CV death or cardiac arrest (p = 0.57) 0.6 0.4 0.2 0 0.5 0.4 % Conclusions • In patients at low risk of CV events after CABG, routine early initiation of ACE inhibitor therapy does not appear to improve clinical outcome up to 3 years after CABG Quinapril (n = 1,280) Placebo (n = 1,273) Rouleau JL, et al. Circulation 2008;117:24-31

More Related